• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

DC briefing boosts collaborative effort

Article

Washington, DC-A congressional briefing held recently at the National Eye Institute (NEI) of the National Institutes of Health has highlighted the need for research partnerships to fight diabetic retinopathy effectively.

Washington, DC-A congressional briefing held recently at the National Eye Institute (NEI) of the National Institutes of Health has highlighted the need for research partnerships to fight diabetic retinopathy effectively.

The briefing featured Thomas W. Gardner, MD, MS, a diabetes researcher, clinician, and professor of ophthalmology and cellular and molecular physiology at the Pennsylvania State University Milton S. Hershey Medical Center, part of the Diabetic Retinopathy Clinical Research Network.

During the 1-day event, Dr. Gardner met with Rep. Gene Green (D-TX), a co-chairman of the Congressional Vision Caucus with NIH oversight, as well as senators Arlen Specter and Rick Santorum (both R-PA).

The network includes 545 experts at 163 clinical sites in 43 states and is one of several collaborative efforts funded by the NEI over the past 30 years to study diabetic retinopathy.

These networks have led to effective diabetic retinopathy treatments that have reduced blindness by 90% and saved $1.6 billion annually in health-care costs, the NEI said.

Related Videos
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
© 2024 MJH Life Sciences

All rights reserved.